United States Hepatitis B Vaccines Market Report 2017

October 2017 | 96 pages | ID: UA0FF2EBD91EN
QYResearch

Abstracts

In this report, the United States Hepatitis B Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Hepatitis B Vaccines in these regions, from 2012 to 2022 (forecast).

United States Hepatitis B Vaccines market competition by top manufacturers/players, with Hepatitis B Vaccines sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• GlaxoSmithKline
• Merck
• Sanofi Pasteur
• Dynavax Technologies
• Janssen Pharmaceuticals
• LG Life Sciences
• Kaketsuken
• Shenzhen Kangtai Biological Products

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Mono Vaccines
• Combination Vaccines

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• adr
• adw
• ayr
• ayw

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Hepatitis B Vaccines Market Report 2017

1 HEPATITIS B VACCINES OVERVIEW

1.1 Product Overview and Scope of Hepatitis B Vaccines
1.2 Classification of Hepatitis B Vaccines by Product Category
  1.2.1 United States Hepatitis B Vaccines Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Hepatitis B Vaccines Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Mono Vaccines
  1.2.4 Combination Vaccines
1.3 United States Hepatitis B Vaccines Market by Application/End Users
  1.3.1 United States Hepatitis B Vaccines Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 adr
  1.3.3 adw
  1.3.4 ayr
  1.3.5 ayw
1.4 United States Hepatitis B Vaccines Market by Region
  1.4.1 United States Hepatitis B Vaccines Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Hepatitis B Vaccines Status and Prospect (2012-2022)
  1.4.3 Southwest Hepatitis B Vaccines Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Hepatitis B Vaccines Status and Prospect (2012-2022)
  1.4.5 New England Hepatitis B Vaccines Status and Prospect (2012-2022)
  1.4.6 The South Hepatitis B Vaccines Status and Prospect (2012-2022)
  1.4.7 The Midwest Hepatitis B Vaccines Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Hepatitis B Vaccines (2012-2022)
  1.5.1 United States Hepatitis B Vaccines Sales and Growth Rate (2012-2022)
  1.5.2 United States Hepatitis B Vaccines Revenue and Growth Rate (2012-2022)

2 UNITED STATES HEPATITIS B VACCINES MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Hepatitis B Vaccines Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Hepatitis B Vaccines Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Hepatitis B Vaccines Average Price by Players/Suppliers (2012-2017)
2.4 United States Hepatitis B Vaccines Market Competitive Situation and Trends
  2.4.1 United States Hepatitis B Vaccines Market Concentration Rate
  2.4.2 United States Hepatitis B Vaccines Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Hepatitis B Vaccines Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES HEPATITIS B VACCINES SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Hepatitis B Vaccines Sales and Market Share by Region (2012-2017)
3.2 United States Hepatitis B Vaccines Revenue and Market Share by Region (2012-2017)
3.3 United States Hepatitis B Vaccines Price by Region (2012-2017)

4 UNITED STATES HEPATITIS B VACCINES SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Hepatitis B Vaccines Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Hepatitis B Vaccines Revenue and Market Share by Type (2012-2017)
4.3 United States Hepatitis B Vaccines Price by Type (2012-2017)
4.4 United States Hepatitis B Vaccines Sales Growth Rate by Type (2012-2017)

5 UNITED STATES HEPATITIS B VACCINES SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Hepatitis B Vaccines Sales and Market Share by Application (2012-2017)
5.2 United States Hepatitis B Vaccines Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES HEPATITIS B VACCINES PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 GlaxoSmithKline
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Hepatitis B Vaccines Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 GlaxoSmithKline Hepatitis B Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Merck
  6.2.2 Hepatitis B Vaccines Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Merck Hepatitis B Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Sanofi Pasteur
  6.3.2 Hepatitis B Vaccines Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Sanofi Pasteur Hepatitis B Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Dynavax Technologies
  6.4.2 Hepatitis B Vaccines Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Dynavax Technologies Hepatitis B Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Janssen Pharmaceuticals
  6.5.2 Hepatitis B Vaccines Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Janssen Pharmaceuticals Hepatitis B Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 LG Life Sciences
  6.6.2 Hepatitis B Vaccines Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 LG Life Sciences Hepatitis B Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Kaketsuken
  6.7.2 Hepatitis B Vaccines Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Kaketsuken Hepatitis B Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Shenzhen Kangtai Biological Products
  6.8.2 Hepatitis B Vaccines Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Shenzhen Kangtai Biological Products Hepatitis B Vaccines Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview

7 HEPATITIS B VACCINES MANUFACTURING COST ANALYSIS

7.1 Hepatitis B Vaccines Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Hepatitis B Vaccines

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Hepatitis B Vaccines Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Hepatitis B Vaccines Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES HEPATITIS B VACCINES MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Hepatitis B Vaccines Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Hepatitis B Vaccines Sales Volume Forecast by Type (2017-2022)
11.3 United States Hepatitis B Vaccines Sales Volume Forecast by Application (2017-2022)
11.4 United States Hepatitis B Vaccines Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Hepatitis B Vaccines
Figure United States Hepatitis B Vaccines Market Size (K Units) by Type (2012-2022)
Figure United States Hepatitis B Vaccines Sales Volume Market Share by Type (Product Category) in 2016
Figure Mono Vaccines Product Picture
Figure Combination Vaccines Product Picture
Figure United States Hepatitis B Vaccines Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Hepatitis B Vaccines by Application in 2016
Figure adr Examples
Table Key Downstream Customer in adr
Figure adw Examples
Table Key Downstream Customer in adw
Figure ayr Examples
Table Key Downstream Customer in ayr
Figure ayw Examples
Table Key Downstream Customer in ayw
Figure United States Hepatitis B Vaccines Market Size (Million USD) by Region (2012-2022)
Figure The West Hepatitis B Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Hepatitis B Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Hepatitis B Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Hepatitis B Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Hepatitis B Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Hepatitis B Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Hepatitis B Vaccines Sales (K Units) and Growth Rate (2012-2022)
Figure United States Hepatitis B Vaccines Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Hepatitis B Vaccines Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Hepatitis B Vaccines Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Hepatitis B Vaccines Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Hepatitis B Vaccines Sales Share by Players/Suppliers
Figure 2017 United States Hepatitis B Vaccines Sales Share by Players/Suppliers
Figure United States Hepatitis B Vaccines Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Hepatitis B Vaccines Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Hepatitis B Vaccines Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Hepatitis B Vaccines Revenue Share by Players/Suppliers
Figure 2017 United States Hepatitis B Vaccines Revenue Share by Players/Suppliers
Table United States Market Hepatitis B Vaccines Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Hepatitis B Vaccines Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Hepatitis B Vaccines Market Share of Top 3 Players/Suppliers
Figure United States Hepatitis B Vaccines Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Hepatitis B Vaccines Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Hepatitis B Vaccines Product Category
Table United States Hepatitis B Vaccines Sales (K Units) by Region (2012-2017)
Table United States Hepatitis B Vaccines Sales Share by Region (2012-2017)
Figure United States Hepatitis B Vaccines Sales Share by Region (2012-2017)
Figure United States Hepatitis B Vaccines Sales Market Share by Region in 2016
Table United States Hepatitis B Vaccines Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Hepatitis B Vaccines Revenue Share by Region (2012-2017)
Figure United States Hepatitis B Vaccines Revenue Market Share by Region (2012-2017)
Figure United States Hepatitis B Vaccines Revenue Market Share by Region in 2016
Table United States Hepatitis B Vaccines Price (USD/Unit) by Region (2012-2017)
Table United States Hepatitis B Vaccines Sales (K Units) by Type (2012-2017)
Table United States Hepatitis B Vaccines Sales Share by Type (2012-2017)
Figure United States Hepatitis B Vaccines Sales Share by Type (2012-2017)
Figure United States Hepatitis B Vaccines Sales Market Share by Type in 2016
Table United States Hepatitis B Vaccines Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Hepatitis B Vaccines Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Hepatitis B Vaccines by Type (2012-2017)
Figure Revenue Market Share of Hepatitis B Vaccines by Type in 2016
Table United States Hepatitis B Vaccines Price (USD/Unit) by Types (2012-2017)
Figure United States Hepatitis B Vaccines Sales Growth Rate by Type (2012-2017)
Table United States Hepatitis B Vaccines Sales (K Units) by Application (2012-2017)
Table United States Hepatitis B Vaccines Sales Market Share by Application (2012-2017)
Figure United States Hepatitis B Vaccines Sales Market Share by Application (2012-2017)
Figure United States Hepatitis B Vaccines Sales Market Share by Application in 2016
Table United States Hepatitis B Vaccines Sales Growth Rate by Application (2012-2017)
Figure United States Hepatitis B Vaccines Sales Growth Rate by Application (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Hepatitis B Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Hepatitis B Vaccines Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Hepatitis B Vaccines Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline Hepatitis B Vaccines Revenue Market Share in United States (2012-2017)
Table Merck Basic Information List
Table Merck Hepatitis B Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Merck Hepatitis B Vaccines Sales Growth Rate (2012-2017)
Figure Merck Hepatitis B Vaccines Sales Market Share in United States (2012-2017)
Figure Merck Hepatitis B Vaccines Revenue Market Share in United States (2012-2017)
Table Sanofi Pasteur Basic Information List
Table Sanofi Pasteur Hepatitis B Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Pasteur Hepatitis B Vaccines Sales Growth Rate (2012-2017)
Figure Sanofi Pasteur Hepatitis B Vaccines Sales Market Share in United States (2012-2017)
Figure Sanofi Pasteur Hepatitis B Vaccines Revenue Market Share in United States (2012-2017)
Table Dynavax Technologies Basic Information List
Table Dynavax Technologies Hepatitis B Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Dynavax Technologies Hepatitis B Vaccines Sales Growth Rate (2012-2017)
Figure Dynavax Technologies Hepatitis B Vaccines Sales Market Share in United States (2012-2017)
Figure Dynavax Technologies Hepatitis B Vaccines Revenue Market Share in United States (2012-2017)
Table Janssen Pharmaceuticals Basic Information List
Table Janssen Pharmaceuticals Hepatitis B Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Janssen Pharmaceuticals Hepatitis B Vaccines Sales Growth Rate (2012-2017)
Figure Janssen Pharmaceuticals Hepatitis B Vaccines Sales Market Share in United States (2012-2017)
Figure Janssen Pharmaceuticals Hepatitis B Vaccines Revenue Market Share in United States (2012-2017)
Table LG Life Sciences Basic Information List
Table LG Life Sciences Hepatitis B Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure LG Life Sciences Hepatitis B Vaccines Sales Growth Rate (2012-2017)
Figure LG Life Sciences Hepatitis B Vaccines Sales Market Share in United States (2012-2017)
Figure LG Life Sciences Hepatitis B Vaccines Revenue Market Share in United States (2012-2017)
Table Kaketsuken Basic Information List
Table Kaketsuken Hepatitis B Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Kaketsuken Hepatitis B Vaccines Sales Growth Rate (2012-2017)
Figure Kaketsuken Hepatitis B Vaccines Sales Market Share in United States (2012-2017)
Figure Kaketsuken Hepatitis B Vaccines Revenue Market Share in United States (2012-2017)
Table Shenzhen Kangtai Biological Products Basic Information List
Table Shenzhen Kangtai Biological Products Hepatitis B Vaccines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Shenzhen Kangtai Biological Products Hepatitis B Vaccines Sales Growth Rate (2012-2017)
Figure Shenzhen Kangtai Biological Products Hepatitis B Vaccines Sales Market Share in United States (2012-2017)
Figure Shenzhen Kangtai Biological Products Hepatitis B Vaccines Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Hepatitis B Vaccines
Figure Manufacturing Process Analysis of Hepatitis B Vaccines
Figure Hepatitis B Vaccines Industrial Chain Analysis
Table Raw Materials Sources of Hepatitis B Vaccines Major Players/Suppliers in 2016
Table Major Buyers of Hepatitis B Vaccines
Table Distributors/Traders List
Figure United States Hepatitis B Vaccines Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Hepatitis B Vaccines Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Hepatitis B Vaccines Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Hepatitis B Vaccines Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Hepatitis B Vaccines Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Hepatitis B Vaccines Sales Volume (K Units) Forecast by Type in 2022
Table United States Hepatitis B Vaccines Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Hepatitis B Vaccines Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Hepatitis B Vaccines Sales Volume (K Units) Forecast by Application in 2022
Table United States Hepatitis B Vaccines Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Hepatitis B Vaccines Sales Volume Share Forecast by Region (2017-2022)
Figure United States Hepatitis B Vaccines Sales Volume Share Forecast by Region (2017-2022)
Figure United States Hepatitis B Vaccines Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources